SCCM
AVNS

Schafer Cullen Capital Management’s Avanos Medical AVNS Stock Holding History

Schafer Cullen Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-145,768
Closed -$6.63M – 310
2014
Q4 		$6.63M Buy
+145,768
New +$5.73M 0.08% 97

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Schafer Cullen Capital Management's AVNS Position: Q1 2015 in Review

Schafer Cullen Capital Management sold out of Avanos Medical (AVNS) in Q1 2015, closing a stake of 145,768 shares — an estimated $6.63M sold.

Schafer Cullen Capital Management first reported a position in AVNS in Q4 2014 and held it in 1 quarter. The position peaked at $6.63M in Q4 2014. 448 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

  • Schafer Cullen Capital Management reported no remaining Avanos Medical position as of Q1 2015 after selling out during the quarter.
  • Schafer Cullen Capital Management sold 145,768 Avanos Medical shares in Q1 2015, an estimated $6.63M.
  • Schafer Cullen Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 1 quarter.
  • Schafer Cullen Capital Management's Avanos Medical position peaked at $6.63M in Q4 2014.
  • 448 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Schafer Cullen Capital Management's 13F filing for Q1 2015, filed 15 May 2015.